56 / 80
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 3, May/June 2017
190
AFRICA
of the American College of Cardiology/American Heart Association
task force on performance measures (writing committee to develop
performance measures for ST-elevation and non-ST-elevation myocar-
dial infarction).
J Am Coll Cardiol
2008;
52
(24): 2046–2099.
9.
The TIMI study group. The Thrombolysis in Myocardial Infarction
(TIMI) trial. Phase I findings.
N Engl J Med
. 1985;
312
(14): 932–936.
10. Soon CY, Chan WX, Tan HC. The impact of time-to-balloon on
outcomes in patients undergoing modern primary angioplasty for acute
myocardial infarction.
Singapore Med J
2007;
48
(2): 131–136.
11. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka
PA,
et al.
; Chamber Quantification writing group; American Society of
Echocardiography’s Guidelines and Standards Committee; European
Association of Echocardiography. Recommendations for chamber quan-
tification: a report from the American Society of Echocardiography’s
Guidelines and Standards Committee and the Chamber Quantification
writing group, developed in conjunction with the European Association
of Echocardiography, a branch of the European Society of Cardiology.
J Am Soc Echocardiogr
2005;
18
(12): 1440–1463.
12. Harold JG, Bass TA, Bashore TM, Brindis RG, Brush JE Jr, Burke
JA,
et al
. ACCF/AHA/SCAI 2013 update of the clinical competence
statement on coronary artery interventional procedures: a report of
the American College of Cardiology Foundation/American Heart
Association/American College of Physicians Task Force on Clinical
Competence and Training (writing committee to revise the 2007 Clinical
Competence Statement on Cardiac Interventional Procedures).
J Am
Coll Cardiol
2013;
62
(4): 357–396.
13. Van’t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ,
Zijlstra F. Angiographic assessment of myocardial reperfusion in
patients treated with primary angioplasty for acute myocardial infarc-
tion: myocardial blush grade. Zwolle myocardial infarction study group.
Circulation
1998;
97
(23): 2302–2306.
14. Ito H, Tomooka T, Sakai N, Yu H, Higashino Y, Fujii K,
et al
. Lack
of myocardial perfusion immediately after successful thrombolysis.
A predictor of poor recovery of left ventricular function in anterior
myocardial infarction.
Circulation
1992;
85
(5): 1699–1705.
15. Poli A, Fetiveau R, Vandoni P, del Rosso G, D’Urbano M, Seveso G,
et al
. Integrated analysis of myocardial blush and ST-segment elevation
recovery after successful primary angioplasty: Real-time grading of
microvascular reperfusion and prediction of early and late recovery of
left ventricular function
. Circulation
2002;
106
(3): 313–318.
16. Stone GW, Peterson MA, Lansky AJ, Dangas G, Mehran R, Leon MB.
Impact of normalized myocardial perfusion after successful angioplasty
in acute myocardial infarction.
J Am Coll Cardiol
2002;
39
(4): 591–597.
17. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P,
Cerisano G, Antoniucci D. Impact of microvascular dysfunction on left
ventricular remodeling and long-term clinical outcome after primary
coronary angioplasty for acute myocardial infarction.
Circulation
2004;
109
(9): 1121–1126.
18. De Luca G, van’t Hof AW, de Boer MJ, Hoorntje JC, Gosselink AT,
Dambrink JH,
et al
. Impaired myocardial perfusion is a major expla-
nation of the poor outcome observed in patients undergoing primary
angioplasty for ST-segment-elevation myocardial infarction and signs
of heart failure.
Circulation
2004;
109
(8): 958–961.
19. Hahn JY, Song YB, Gwon HC, Choe YH, Kim JH, Sung J,
et al
.
Relation of left ventricular infarct transmurality and infarct size after
primary percutaneous coronary angioplasty to time from symptom
onset to balloon inflation.
Am J Cardiol
2008;
102
(9): 1163–1169.
20. Prasad A, Gersh BJ, Mehran R, Brodie BR, Brener SJ, Dizon JM,
et
al
. Effect of ischemia duration and door-to-balloon time on myocar-
dial perfusion in ST-segment elevation myocardial infarction: an
analysis from HORIZONS-AMI trial (Harmonizing Outcomes with
Revascularization and Stents in Acute Myocardial Infarction).
J Am
Coll Cardiol Cardiovasc Interv
2015;
8
(15): 1966–1974.
21. Prasad A, Stone GW, Holmes DR, Gersh B. Reperfusion injury, micro-
vascular dysfunction, and cardioprotection: the “dark side” of reperfu-
sion.
Circulation
2009;
120
(21): 2105–2112.
22. Basso C, Corbetti F, Silva C, Abudureheman A, Lacognata C,
Cacciavillani L,
et al
. Morphologic validation of reperfused hemor-
rhagic myocardial infarction by cardiovascular magnetic resonance.
Am
J Cardiol
2007;
100
(8): 1322–1327.
23. Sharpe N. Ventricular remodeling following myocardial infarction.
Am
J Cardiol
1992;
70
(10): 20C–26C.
24. Anthonio RL, van Veldhuisen DJ, van Gilst WH. Left ventricular dilata-
tion after myocardial infarction: ACE inhibitors, beta-blockers, or both?
J Cardiovasc Pharmacol
1998;
32
(Suppl 1): S1–8.
25. Shuichi T, Satoru S, Takeshi B, Hiroshi T, Naohiko A, Yoshio Y,
et al
.
Predictors of left ventricular remodeling in patients with acute myocar-
dial infarction participating in cardiac rehabilitation.
Circ J
2004;
68
(3):
214–219.
26. Epifanio HB, Zornoff LA, Matsubara BB, de Paiva SA, Inoue
RM, Matsubara LS. Myocardial remodeling after experimental acute
myocardial infarction in rats. Effect of renin-angiotensin-aldosterone
blockade.
Arq Bras Cardiol
2005;
84
(1): 10–14.
27. Patten RD, Soman P. Prevention and reversal of LV remodeling with
neurohormonal inhibitors.
Curr Treat Options Cardiovasc Med
2004;
6
(4): 313–325.